Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies Columbia, MD – June 5, 2019 – MedTech Breakthrough, an independent organization that recognizes the top companies and solutions in the global health and medical technology market, today announced that it has selected Welldoc’s BlueStar® platform, digital therapeutic for people with type 2 diabetes,…
Type: Press Release
Anand Iyer, PhD, Chief Strategy Officer, Accepts “Established App” Award at Diabetes Technology Society’s 2019 Digital Diabetes Congress Columbia, MD – May 15, 2019 – Today, Welldoc announced that the Diabetes Technology Society has selected BlueStar digital therapeutic as the winner of the Digital Diabetes Congress 2019 Mobile App Contest, in the category of “Established…
Milwaukee, WI and Columbia, MD – May 14, 2019 – The Business Health Care Group (BHCG), a coalition of employers located throughout eastern Wisconsin, recently announced a partnership with Welldoc, a leading digital therapeutic company working with individuals with chronic diseases. The company will offer its award-winning digital assistant BlueStar program to BHCG member employers…
Durham, NC and Columbia, MD – April 30, 2019 — Validic, the leading provider of data solutions for remote monitoring and virtual engagement, and Welldoc, a leading digital therapeutic company, today announced their partnership to broaden the access and integration of personal health data within the Welldoc BlueStar® platform. The collaboration will allow BlueStar users…
Burnaby, British Columbia, and Columbia, MD – April 9, 2019—LifeScan, Inc. today introduced the OneTouch Reveal Plus™ mobile app, which received Health Canada license and will soon be available to health benefit plans for adults living with type 1 and type 2 diabetes. Powered by Welldoc’s BlueStar® technology – OneTouch Reveal Plus™ will offer individualized,…
Milwaukee, WI and Columbia, MD – April 3, 2019 – Today, Welldoc and Children’s Community Health Plan (CCHP) announced the introduction of BlueStar®, Welldoc’s FDA-cleared, proven digital therapeutic, to CCHP’s commercially-insured and Medicaid members. BlueStar, an in-app coach designed to engage people with type 2 diabetes, delivers personalized, real-time feedback, as well as diabetes educational tools that…
More than 10,000 Aetna members invited to use mobile app with artificial intelligence from Welldoc and LifeScan Inc. Hartford, CT and Columbia, MD – Today, Healthagen, an Aetna business unit within CVS Health, and Welldoc, in collaboration with LifeScan Inc., announced details of a study to evaluate the use and potential health benefits of OneTouch Reveal®…
Welldoc’s chronic disease portfolio grows with new features to support people with both type 1 and type 2 diabetes Columbia, MD – February 6, 2019 – Welldoc®, a leading digital health company, announced today its filing at the end of 2018 with the U.S. Food and Drug Administration (FDA) for 510(k) clearance of additional features…
Columbia, MD – January 7, 2019 – Welldoc®, a leading digital health company, announced today that it has secured a technology patent (based on U.S. Patent Application No. 15/923,010) from the United States Patent and Trademark Office for the Software Engine Technology that powers its BlueStar® digital therapeutic. “The awarding of this tenth technology patent…
Columbia, Maryland, November 9, 2018 – Welldoc®, a leading digital health company, announced today that its executives and digital health, diabetes and healthcare industry thought leaders will speak and/or participate in events at prominent diabetes and healthcare conferences this Fall. The list of events is as follows: 18th Annual Diabetes Technology Meeting November 8-10, 2018, Bethesda…